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ABSTRACT 
Direct Exercise Metabolite Inhibition of Breast Cancer Cell Growth. (May 2014) 
 
Alexandra Christine Schneider 
Department of Health and Kinesiology 
Texas A&M University 
 
Research Advisor: Dr. Steven Riechman 
Department of Health and Kinesiology 
 
The purpose of this study is to determine the effect of lactate released from contracting muscle 
on breast cancer cell growth. Epidemiological studies clearly show that physically active women 
have a significantly reduced risk of developing breast cancer but the mechanism is unknown. It is 
well known that during exercise, contracting muscle releases many different substances, 
including hydrogen ions, lactate, adenosine diphosphate, ammonia, as well as many proteins. 
Therefore, it is hypothesized that an exercise-induced, muscle specific factor directly suppresses 
breast tumor growth. Likely candidates include a protein or exercise related metabolite.  This 
research will specifically address lactate’s role in breast cancer growth. 
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Influence of exercise on breast cancer 
An increased prevalence in breast cancer has lead to an increase in the amount of research done 
regarding breast cancer prevention and treatment. Although many believe that breast cancer is 
much more curable, it is likely related to the fact that breast cancer is diagnosed in earlier stages 
of its development, therefore leading to higher survival rates due to early treatment 
implementation. It is also known that there are a variety of risk factors that play a role in an 
individual’s likelihood of developing breast cancer. Unfortunately, for example, age, family 
history, and race are aspects of one’s life that cannot be changed. Physical inactivity, however, is 
a modifiable risk factor that, when altered, can significantly influence the likelihood of not only 
developing breast cancer, but also preventing the growth and spreading of it. This fact alone is 
the basis for conducting this experiment, along with the hope of developing a cost effective 
treatment that is available to all individuals. During exercise, contracting skeletal muscle releases 
a number of metabolic factors into circulation, one of which has shown to directly suppress the 
growth of breast tumor cells in preliminary data. In particular, this study focuses on the role of 
lactate in tumor growth suppression. 
 
Exercise metabolites and energy pathways 
During exercise, skeletal muscle excretes a number of metabolic by-products, including proteins, 
hydrogen ions, ammonia, lactate, and many more. When subjected to different exercise bouts, 
skeletal muscle activates different metabolic pathways depending on the energy requirements for 
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that particular exercise session. The metabolic pathways of concern in this study are those that 
involve the release of lactate. Anaerobic Glycolysis and Oxidative Phosphorylation both involve 
the production of lactate. Anaerobic glycolysis relies on the breakdown of glycogen to provide 
energy. Glycogen is converted to glucose, which is then broken down in order to synthesize the 
energy molecule, ATP. During this synthesis, the breakdown of glucose results in the creation of 
the metabolic by-product pyruvate as well as excess hydrogen ions. These substances will 
combine in order to prevent metabolic acidosis, thus creating lactate. When lactate begins to 
accumulate in the blood, the body will eventually reach its lactate threshold. Concentrations past 
this threshold indicate that the body has crossed over into anaerobic metabolism and has 
maximized oxygen utilization. This is in part due to the fact that the brain is only able to use 
glucose for energy. The rest of the body must accommodate the brains’ demands, and therefore 
spare its glycogen stores in order for the brain to maintain its minimal energy requirements. 
Then, the process of oxidative phosphorylation will take place. In this process, pyruvate is 
converted to Acetyl CoA, which will yield a large amount of ATP to sustain the energy demands 
of the body, specifically contracting skeletal muscle.  
 
The Warburg Hypothesis 
Although the systems of the body can function on many different energy pathways, the Warburg 
Hypothesis suggests that tumor cells can only survive on glycolytic energy metabolism (Chen, 
2008). Warburg suggested that by blocking the tumor’s ability to use glycolytic metabolism, an 
antiproliferative and apoptotic effect is observed. As previously mentioned, in response to higher 
energy demands, the body must shift in to different metabolic pathways to sustain energy 
requirements. During exercise, the increases in metabolism in skeletal muscle typically require a 
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rapid shift in energy partitioning and mobilization. Thus, the overarching hypothesis is that 
skeletal muscle, in response to accelerated metabolism due to muscle stimulation, releases a 
metabolite that acts directly on all uninvolved tissues in suppressing glycolytic metabolism in 
order to spare glucose for essential and immediate functions (primarily brain and skeletal 
muscle). Suppression of glycolytic metabolism compels oxidative metabolism and mitochondrial 
adaptation. In cancer cells, compulsory activation of dysfunctional mitochondria results in 
apoptosis. It is recognized that skeletal muscle releases multiple metabolites such as lactate, 
hydrogen ion, potassium, adenosine and nitric oxide that have many local and systemic effects to 
adapt to acute exercise challenge mainly by redistribution of blood flow. I am hypothesizing that 
the tumor suppressing effects will only be seen if lactic acid is present, which would be 




Preliminary data gathered from initial studies by Dr. Riechman provide evidence that a muscle 
specific factor is released into circulation and directly suppresses tumor growth. In a rat hindlimb 
that is perfused with a red blood cell free artificial blood and stimulated to contract, the resulting 
perfusate coming out of muscle inhibits breast cancer cells in vitro and tumors in vivo. In cell 
culture, a 40-50% reduction in total cell number is observed in the MCF7 bioassay in stimulated 
perfusate vs. unstimulated muscle perfusate. In two separate experiments where muscle perfusate 
was injected into MCF7 tumor bearing mice, tumor size was significantly suppressed only in 
those injected with stimulated muscle perfusate. This was consistent with the significantly 
elevated markers of apoptosis.  





Female wistar rat hindlimbs, following a hemicorpus preparation, will be perfused using an 
oxygenated, red blood cell-free Krebs-Henseleit (K-HB) medium (pH 7.4), containing a Muscle 
Biology (Fluckey) and Human Countermeasures Laboratory (Riechman) developed protein free 
osmoregulator additives as well as standard albumin osmoregulator and 5 mM glucose.  After an 
initial control period of 10 minutes of perfusion, rat hindlimbs will be stimulated with high 
frequency pulses to elicit high intensity muscle actions.  During muscle actions, flow rate will be 
elevated to 21 ml per minute to accommodate activity.  Perfusate will be collected separately 
during the initial control perfusion period and after the onset of muscle contractions. This 10 
minute control/resting condition followed by 10 minute stimulation/exercise is our basic design 
but we will repeat the experiment two additional ways. The time under perfusion control will be 
10 minutes control/resting followed by another 10 minutes of control/resting. Finally, we will 
perform the stimulation/exercise in the first 10 minutes followed by 10 minutes of control/resting. 
For the MCF7 assays we will also add a perfusate control group that will be unused red blood 
cell-free Krebs-Henseleit (K-HB) medium otherwise treated the same as experimental samples.  
These additional controls will ensure that our observed effects are due to muscle contraction and 
not just due to muscle contractions coming at the end of the experiment when it is possible that 
the experimental conditions are causing a detrimental effect of the muscle. 
 
 
	   8	  
Lactate analysis 
As previously mentioned, the experiment is designed to monitor the levels of various exercise 
metabolites, the primary interest being in lactic acid. Aliquots of perfusate will be taken every 30 
seconds over the course of the 20 minutes to be analyzed for changes in lactate levels. This will 
be important in determining whether or not lactate plays a key role in the inhibition of MCF7 
breast cancer cells. The concentration of lactate will also be compared to the changes in pH 
exhibited in the muscle perfusate. This will help in attributing the chemotherapeutic effects to pH 
change, lactate concentration increase, general metabolic changes, or to some other metabolite, 
primarily the interest being in a protein. 
 
MCF7 Bioassay 
These experiments will use cell culture as a bioassay for the determination of the 
antiproliferative/apoptotic effects of our muscle perfusion isolates. The breast cancer cell lines 
selected will be one estrogen receptor positive (ER+) (MCF7+E2 pellet) and one negative (ER-) 
(MDA MB 231). Muscle perfusate from the various conditions described under hindlimb 
perfusion will be lyophilized and resuspended in sterile water for the bioassay. Additionally, 
some control samples will have lactate added to equivalent levels as exercise perfusate to 
determine lactate specific effects.  The extracts will first be tested for mitotic and apoptotic 
effects in vitro in the two cell lines using 5-bromo-2-deoxyuridine incorporation (BrdU) and 
TUNEL assays (Dupont-Versteegden et al., 2006b). Harvested cells will be rapidly frozen to the 
temperature of liquid nitrogen, pulverized, lysed and homogenized in a specially designed lysis 
buffer to maintain phosphorylation states of specific proteins at the time of harvest for cell 
signaling studies. We will then load equal amounts of protein from lysates to a traditional 
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discontinuous Tris-Glycine buffer system developed by Ornstein and Davis (Ornstein L, 
1964,Davis J, 1964)) and further perfected by Laemmli (Laemmli U, 1970) to separate proteins 
using SDS-PAGE. Thereafter proteins will be transferred to nitrocellulose membranes and 
probed for proteins regulating growth/survival in the muscle cell (Akt/mTOR pathway, and the 
mitogen activated protein kinase family), as well as specific markers of apoptosis and proteolysis. 
Specifically, cell nuclei will be partitioned in order to measure levels of BrdU incorporation (a 
marker of cellular/nuclear proliferation), and specific proteases, including ubiquitin and ubiquitin 
ligases, will be assessed as proteolytic markers using methodologies we have previously 
employed in skeletal muscle (Dupont-Versteegden et al., 2006a). Apoptosis will be measured 
using TUNEL assay, and the expression of signaling intermediates, including Bcl and Bax and I-
kappa-B will be measured.  





As our timeline indicated, our experiments were planned for early Spring 2014. However, our 
IACUC approval required some revisions before we were able to place the order for our animals. 
We promptly made the necessary changes, however, Dr. Riechman continued to receive 
notifications indicating that additional revisions were needed, although we were certain these 
corrections had been handled. After much disdain, Dr. Riechman contacted the head of the 
IACUC board to find out why revisions were still necessary and what still needed to be done in 
order to receive final approval. We were informed that there had been a glitch in the system and 
our IACUC proposal was continually being submitted as a new proposal, rather than as a revised 
proposal. Our proposal was eventually approved and we were able to order animals at the 
beginning of March. As you can imagine, this set our project back quite some time and we have 
been struggling to meet our deadlines. 
 
Before any experiments can begin, the Wistar rats had to be put in isolation for at least one week 
in order to adjust to their new environment. After this one-week isolation period, we hoped to 
finally begin our experiment. Unfortunately, scheduling conflicts continued to impede the 
beginning of our experimentation. Although our team could not all be present for the “ground-
breaking” surgery of sorts, Dr. Riechman was able to successfully perform a trial surgery on 
Friday, March 28, 2014. This was important technical, procedural practice to firmly establish the 
coordination of these complex experiments. We were able to establish very precise lactate and 
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glucose measurements that fell in normal physiological ranges. April 4th experiments are planned 
to complete the muscle perfusate and lactate determination for the objectives of this study. 
Our team has continued working diligently to prepare the bioassays and ensure that our lactate 
analyzer is ready for the first successful perfusate collection. As with any research project, things 
never go according to plan and our team has done the best we can with the hand we have been 
dealt. April 4th experiments are planned to complete the muscle perfusate and lactate 
determination for the objectives of this study. 
 
  




Looking to the future 
Without any usable data to run through the lactate analyzer or use in our bioassays, it is difficult 
to make a definitive conclusion regarding the chemotherapeutic effects of lactate at this point in 
time. However, data will continue to be collected over the next few weeks and a conclusion will 
be reached on the role of lactate in MCF7 breast cancer cell growth inhibition.  
Current research supports that blood lactate concentration will increase as a result of exercise. 
We can, without any reasonable doubt, hypothesize that the lactate concentrations will 
consequently vary according to muscle stimulation levels. Our experiment model currently states 
that we will be collecting aliquots every 30 seconds during the rest period as well as during the 
stimulation period. This is to ensure that we are able to directly attribute the change in lactate 
concentration to the stimulation, and not to any other source, such as the length of time the 
perfusion has been running.  
 
During the trial consisting of 10 minutes of rest followed by 10 minutes of rest, we can assume 
that there will be no changes in the level of lactate present in our aliquots. In the trial combining 
10 minutes of rest followed by 10 minutes of exercise, we will expect to see a sharp increase in 
the lactate concentration in each subsequent aliquot beginning at the 10 minute, 30 second 
collection. In the final trail, combining 10 minutes of stimulation, followed by 10 minutes of rest, 
we expect to see a gradual decline in the lactate concentration during the resting period, which 
can be attributed, with much certainty, to the lack of muscle stimulation.  
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Following the collection of all data, we plan to run the aliquots through the lactate analyzer in 
order to track the changes in lactate concentrations. This analysis will be compared to the results 
we obtain from the bioassays. Should we find that the tumor cell growth is inhibited by the 
perfusate collected during the stimulation periods, we can assume that lactate likely has some 
role in the suppression of cell growth. However, is cell growth is inhibited by perfusate collected 
from rest periods, as well as from stimulation periods, then it is likely that the source of the 
chemotherapeutic effects does not come from contracting muscle. Either of these results would 




When I originally began working with Dr. Riechman on this project, I had very high 
expectations of coming out on the other side of this with a hugely expanded knowledge of the 
chemotherapeutic effects of exercise on breast cancer tumor cell growth. I was also somewhat 
naïve to think that we would not run in to any hold-ups or to think that everything would go 
according to plan. This is science – how could I expect that? Although my expectations in that 
regard have not yet been met, I have no doubt that over the course of the next month we will gain 
a great deal of knowledge and will have taken one step closer to pinpointing the source of these 
chemotherapeutic effects. I have indeed come out with a more mature and realistic mindset 
regarding research; as a scientist we must be prepared for the worst while hoping for best, and 
anything in between is just another stepping stone to reach our final goal. It has been hard for me 
to understand how there can be so much research conducted to find a cure for cancer, but yet we 
still don’t have a cure. I now see the light, so to speak.   
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